NEWS

Junevity Raises $10M to Develop Cell Reset Therapeutics for Longevity
Junevity Raises $10M to Develop Cell Reset Therapeutics for Longevity 02/13/2025
Leveragen Announces Strategic Collaboration with Moonlight Bio to Advance T Cell Therapies Using Proprietary Fully Human Single-Domain Antibody Technology
Leveragen Announces Strategic Collaboration with Moonlight Bio to Advance T Cell Therapies Using Proprietary Fully Human Single-Domain Antibody Technology 02/03/2025
PreludeDx Receives FDA Breakthrough Device Designation for DCISionRT® Test for DCIS Breast Cancer Patients PreludeDx (PRNewsfoto/PreludeDx)
PreludeDx Receives FDA Breakthrough Device Designation for DCISionRT® Test for DCIS Breast Cancer Patients PreludeDx (PRNewsfoto/PreludeDx) 01/17/2025
Venova Medical Announces First Subjects Enrolled in VENOS-2 IDE Study of the Velocity Percutaneous AVF System
Venova Medical Announces First Subjects Enrolled in VENOS-2 IDE Study of the Velocity Percutaneous AVF System 01/17/2025
Vevo Therapeutics to Open Source Milestone Tahoe-100M Dataset
Vevo Therapeutics to Open Source Milestone Tahoe-100M Dataset 01/13/2025
Alessa Therapeutics Announces First Patient Enrolled in the Enolen Study for Localized Drug Delivery for Prostate Cancer
Alessa Therapeutics Announces First Patient Enrolled in the Enolen Study for Localized Drug Delivery for Prostate Cancer 01/10/2025
Sana’s cell therapy may be ‘transformative cure’ for type 1 diabetes: analysts
Sana’s cell therapy may be ‘transformative cure’ for type 1 diabetes: analysts 01/10/2025
Aer Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Fexlamose in Chronic Obstructive Pulmonary Disease
Aer Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Fexlamose in Chronic Obstructive Pulmonary Disease 01/09/2025
ScaleReady awards a G-Rex® Grant to Moonlight Bio
ScaleReady awards a G-Rex® Grant to Moonlight Bio 12/20/2024
Alessa Therapeutics Announces Closing $15M Seed Financing
Alessa Therapeutics Announces Closing $15M Seed Financing 12/16/2024
UCSF Congratulates Professor Pamela M. England, PhD, and her spinout company, 153 Therapeutics.
UCSF Congratulates Professor Pamela M. England, PhD, and her spinout company, 153 Therapeutics. 12/12/2024
Chroma Medicine and Nvelop Therapeutics Unite to Form nChroma Bio, Securing $75 Million to Accelerate Genetic Medicines
Chroma Medicine and Nvelop Therapeutics Unite to Form nChroma Bio, Securing $75 Million to Accelerate Genetic Medicines 12/12/2024
Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery
Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery 12/10/2024
Delve Bio Announces Launch of its Groundbreaking Genomic Infectious Disease Test, Delve Detect
Delve Bio Announces Launch of its Groundbreaking Genomic Infectious Disease Test, Delve Detect 12/04/2024
Exai Bio Announces Publication in Nature Communications Highlighting its Generative AI Liquid Biopsy Platform
Exai Bio Announces Publication in Nature Communications Highlighting its Generative AI Liquid Biopsy Platform 11/22/2024